Skip to main content
HR 1718 97th Congress House

A bill to direct that a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis be conducted through the National Institute of…

Official title: A bill to direct that a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis be conducted thr… Show full official titleShow less

Official title: A bill to direct that a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis be conducted through the National Institute of Arthritis, Metabolism, and Digestive Diseases.

Introduced: December 9, 1981 See on congress.gov
Health Drug safety and regulationDrugs and narcoticsJoint diseasesPharmaceutical researchResearch and development
Sign in to write a letter Sign in to watch
This bill died when the 97th Congress ended
It never became law before the 97th Congress (1981–1982) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 9, 1981
Referred to Subcommittee on Health and the Environment.
Feb 5, 1981
Referred to House Committee on Energy and Commerce.
Feb 5, 1981
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 9, 1981

Referred to Subcommittee on Health and the Environment.

 Plain-English summary Congressional Research Service

Directs the Secretary of Health and Human Services, acting through the National Institute of Arthritis, Metabolism, and Digestive Diseases, to: (1) conduct a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis; and (2) report to Congress within one year of enactment of this Act.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Republican 1
R
Rogers, Harold
Kentucky · Dec 9, 1981
FROST, MARTIN
· Feb 5, 1981
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1718: A bill to direct that a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis be conducted through the National Institute of Arthritis, Metabolism, and Digestive Diseases.. 97th Congress. Open America. https://openamerica.io/bill/97-HR-1718/
MLA
"H.R. 1718: A bill to direct that a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis be conducted through the National Institute of Arthritis, Metabolism, and Digestive Diseases.." 97th Congress, 2026, Open America, https://openamerica.io/bill/97-HR-1718/.
Bluebook (legal)
H.R. 1718, 97th Cong. (2026), https://openamerica.io/bill/97-HR-1718/.
Markdown link
[H.R. 1718: A bill to direct that a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis be conducted through the National Institute of Arthritis, Metabolism, and Digestive Diseases.](https://openamerica.io/bill/97-HR-1718/)
Report a problem